The current study was a meta-analysis of 18 large, prospective, randomized, controlled studies with a total of 4146 patients. The included studies had "cardiovascular," "mortality," or "blood pressure ...
Higher sleep apnea specific hypoxic burden was linked to increased 30-day mortality and cardiovascular complications after ...
The obesity and diabetes medication tirzepatide (Mounjaro, Zepbound) reduced obstructive sleep apnea events by as much as two-thirds in new clinical trials. The abstract (but not the complete study) ...
Add Yahoo as a preferred source to see more of our stories on Google. Inspire Sleep Apnea Innovation Around 22 million Americans have sleep apnea. Traditional continuous positive airway pressure, or ...
The weight-loss drug Zepbound was linked to a reduction in obstructive sleep apnea (OSA), according to new research. Pharmaceutical manufacturer Eli Lilly on Wednesday said injections of its obesity ...
DANVILLE, Va. (WSET) — Sovah Health is now offering a new kind of sleep apnea treatment for those who cannot useContinuous Positive Airway Pressure (CPAP) therapy. Obstructive sleep apnea impacts 22 ...
A late-stage trial of Eli Lilly’s weight loss drug Zepbound showed promising results in treating sleep apnea symptoms in obese adults, the company announced Wednesday, the latest findings suggesting ...
A CPAP machine is a medical device often recommended to folks who have sleep apnea or other disruptive sleep conditions. Wearers place a mask over their nose and mouth to deliver a continuous stream ...
Women over 50 with sleep apnea rarely snore loudly or fit the textbook profile. Instead, they show up with anxiety, brain fog ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results